Literature DB >> 17252497

Different mechanisms involved in the vasorelaxant effect of flavonoids isolated from Satureja obovata.

V R Sánchez de Rojas1, B Somoza, T Ortega, A M Villar.   

Abstract

The inhibitory effects of naringenin, eriodictyol, and luteolin (10(-5) and 5 x 10(-5) M), previously isolated from Satureja obovata subsp. obovata var. valentina (Lamiaceae), on rat thoracic aorta were investigated. Flavonoids at the two concentrations assayed (10(-5) and 5 x 10(-5) M) showed different smooth muscle relaxant behaviour in the three phases involved in the noradrenaline (10(-6) M)-induced contractions. The three flavonoids showed an inhibitory effect of the phasic component in order of potency: luteolin > eriodictyol > naringenin. Luteolin and eriodictyol inhibited both tonic-I and tonic-II phases associated to the inhibition of PKC and calcium influx, respectively, whereas naringenin only inhibited the tonic-I phase associated to inhibition of PKC.

Entities:  

Year:  1996        PMID: 17252497     DOI: 10.1055/s-2006-957969

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  2 in total

Review 1.  Vasodilator compounds derived from plants and their mechanisms of action.

Authors:  Francisco J Luna-Vázquez; César Ibarra-Alvarado; Alejandra Rojas-Molina; Isela Rojas-Molina; Miguel Angel Zavala-Sánchez
Journal:  Molecules       Date:  2013-05-17       Impact factor: 4.411

2.  Endothelium-Dependent Effects of Echinodorus grandiflorus (Cham. & Schltdl.) Micheli Mediated by M3-Muscarinic and B2-Bradykininergic Receptors on Peripheral Vascular Resistance and Its Modulatory Effects on K+ Channels in Mesenteric Vascular Beds.

Authors:  Enaile Salviano de Carvalho; Cleide Adriane Signor Tirloni; Rhanany Alan Calloi Palozi; Maysa Isernhagen Schaedler; Lucas Pires Guarnier; Aniely Oliveira Silva; Jonas da Silva Mota; Claudia Andréa Lima Cardoso; Márcio Eduardo de Barros; Arquimedes Gasparotto Junior
Journal:  Evid Based Complement Alternat Med       Date:  2019-01-02       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.